Search This Blog

Tuesday, December 1, 2015

New Data Show Lilly's Once-Weekly Trulicity® (dulaglutide) is Effective as Add-on Treatment to Sulfonylurea (NYSE:LLY)

Trulicity 1.5 mg Demonstrates Superior Efficacy in AWARD-8 Trial



New Data Show Lilly's Once-Weekly Trulicity® (dulaglutide) is Effective as Add-on Treatment to Sulfonylurea (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.